EXEMESTANE INOVAMED
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
EXEMESTANE 25 MG
Available from:
INOVAMED LTD
ATC code:
L02BG06
Pharmaceutical form:
FILM COATED TABLETS
Administration route:
PER OS
Manufactured by:
SYNTHON B.V., NETHERLANDS
Therapeutic group:
EXEMESTANE
Therapeutic indications:
Exemestane Inovamed is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. Exemestane Inovamed is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Exemestane Inovamed is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
Authorization date:
2013-11-01
